title: Confirmation of the antidyskinetic effect of posteroventral pallidotomy by means of an intraoperative apomorphine test.
abstract: We present a series of six consecutive Parkinson's disease patients undergoing posteroventral pallidotomy (PVP), who received an apomorphine injection after thermolesioning the posteroventral region of the internal globus pallidus (GPi) to evaluate the effect of the lesion on drug-induced dykinesias and therefore to proceed with further lesions or to conclude the surgery. Five of six patients failed to present dykinesias or did so to a significantly lesser degree (F [2,10] 42.6; p < 0.0001) so that surgery was concluded. One patient continued having contralateral dyskinesia despite an improvement in rigidity and bradykinesia, therefore, a new track was performed followed by a new lesion. No differences were found between intrasurgical and 1-month postoperative apomorphine test values. This report indicates that the use of an apomorphine test after thermolesioning may provide a reliable tool to check lesion efficacy on dyskinesia. The development of techniques that provide additional clinical information to the electrophysiological recording could help improve the outcome of patients undergoing pallidotomy.
authors.affiliation: Movement Disorders Section, Raul Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina.
authors.forename: M
authors.initials: M
authors.lastname: Merello
authors.forename: A
authors.initials: A
authors.lastname: Cammarota
authors.forename: M I
authors.initials: MI
authors.lastname: Nouzeilles
authors.forename: O
authors.initials: O
authors.lastname: Betti
authors.forename: R
authors.initials: R
authors.lastname: Leiguarda
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents; D001058:Apomorphine; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis* / Q000503:physiopathology; D005260:Female; D005500:Follow-Up Studies; D005917:Globus Pallidus / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007431:Intraoperative Complications / Q000175:diagnosis* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000503:physiopathology / Q000601:surgery*; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
chemical_list: D000978:Antiparkinson Agents; D001058:Apomorphine